摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,2S)-(+)-trans-(2-methylcyclohexyl)methanol | 97276-83-0

中文名称
——
中文别名
——
英文名称
(1S,2S)-(+)-trans-(2-methylcyclohexyl)methanol
英文别名
[(1S,2S)-2-methylcyclohexyl]methanol
(1S,2S)-(+)-trans-(2-methylcyclohexyl)methanol化学式
CAS
97276-83-0
化学式
C8H16O
mdl
——
分子量
128.214
InChiKey
NIDINIHOPRFWFJ-JGVFFNPUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    (1S,2S)-(+)-trans-2-methylcyclohexanecarboxaldehyde 在 dimethyl sulfide borane 作用下, 以95%的产率得到(1S,2S)-(+)-trans-(2-methylcyclohexyl)methanol
    参考文献:
    名称:
    通过有机硼烷进行手性合成。3. 将基本 100% 光学纯度的硼酸酯转化为具有极高对映体纯度的醛、酸和同系醇
    摘要:
    L'homologation des烷基-2二氧硼烷-1,3,2 en α-甲氧基烷基-2dioxaborinannes-1,3,2 (I) est effectuee par traitement avec le [甲氧基苯硫基] 甲基锂 suivi d'un traitement avec HgCl 2 。Les compose I sont oxydes avec H 2 O 2 Pour donner les aldehydes 通讯员,avec une tres forte purete optique。Les aldehydes peuvent etre reduits et oxydes en utilisant各自 le borane-methylesulfure et l'acide chromique aqueux
    DOI:
    10.1021/ja00303a026
点击查看最新优质反应信息

文献信息

  • Purine compounds and methods of use thereof
    申请人:Salzman L. Andrew
    公开号:US20070238694A1
    公开(公告)日:2007-10-11
    The invention relates to Purine Compounds; compositions comprising an effective amount of a Purine Compound; and methods for reducing a subject's rate of metabolism or protecting a subject's heart against myocardial damage during cardioplegia; or for treating or preventing a cardiovascular disease, a neurological disorder, an ischemic condition, a reperfusion injury, obesity, a wasting disease, diabetes, a cellular proliferative disorder, a skin disorder, a radiation-induced injury, a wound or an inflammatory disease comprising administering an effective amount of a Purine Compound to a subject in need thereof.
    这项发明涉及嘌呤化合物;包含有效量嘌呤化合物的组合物;以及用于减少受试者代谢率或在心脏停搏期间保护受试者心脏免受心肌损伤,或用于治疗或预防心血管疾病、神经系统紊乱、缺血情况、再灌注损伤、肥胖、消耗性疾病、糖尿病、细胞增殖紊乱、皮肤疾病、辐射诱导损伤、创伤或炎症疾病的方法,包括向需要的受试者施用有效量的嘌呤化合物。
  • Isoxazoline-substituted benzamide compound and pesticide
    申请人:Mita Takeshi
    公开号:US20070066617A1
    公开(公告)日:2007-03-22
    An isoxazoline-substituted benzamide compound of formula (1) or a salt thereof: wherein A 1 , A 2 and A 3 independently of one another are carbon atom or nitrogen atom, G is benzene ring, etc., X is halogen atom, C 1 -C 6 haloalkyl, etc., Y is halogen atm, C 1 -C 6 alkyl, etc., R 1 is C 1 -C 12 alkyl arbitrarily substituted with R 16 , C 3 -C 2 alkenyl, arbitrarily substituted with R 16 is oxygen atom or sulfur atom, —N(R 20 )R 19 , etc., R 2 is hydrogen atom, C 1 -C 4 alkoxy C 1 -C 6 alkyl, etc., R 3 is C 1 -C 6 haloalkyl, etc., R 16 is halogen atom, cyano, phenyl substituted with (Z) p1 , D-1 to D-60, E-1 to E-49, etc., R 19 is phenyl, phenyl substituted with (Z) p1 , etc., R 20 is hydrogen atom, C 1 -C 6 alkyl, etc., Z is halogen atom, nitro, C 1 -C 4 alkoxy, etc., D-1 to D-60 are 5- or 6-membered aromatic heterocyclic rings, E-1 to E-49 are 5- or 6-membered saturated heterocyclic rings, m is an integer of 0 to 5, n is an integer of 0 to 4, p1 is an integer of 1 to 5. The pesticide containing these compounds.
    一种公式(1)所示的异噁唑基取代的苯甲酰胺化合物或其盐: 其中A1,A2和A3独立地为碳原子或氮原子,G为苯环等,X为卤素原子,C1-C6卤代烷基等,Y为卤素原子,C1-C6烷基等,R1是任意取代的C1-C12烷基,或者任意取代的C3-C2烯基,取代基为R16,R16是卤素原子,基,苯基取代的(Z)p1,D-1至D-60,E-1至E-49等,R2为氢原子,C1-C4烷氧基C1-C6烷基等,R3为C1-C6卤代烷基等,R19为苯基,苯基取代的(Z)p1等,R20为氢原子,C1-C6烷基等,Z为卤素原子,硝基,C1-C4烷氧基等,D-1至D-60为5-或6-成员芳香杂环环,E-1至E-49为5-或6-成员饱和杂环,m为0至5的整数,n为0至4的整数,p1为1至5的整数。包含这些化合物的杀虫剂
  • 2-AMINOBENZAMIDE DERIVATIVE
    申请人:Kuramochi Takahiro
    公开号:US20090233900A1
    公开(公告)日:2009-09-17
    To provide a novel and excellent agent for treating or preventing nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like, based on the inhibitory action on the capsaicin receptor VR1 activation. The present invention was accomplished by confirming that a benzamide derivative characterized by the possession of a benzene ring in which a single ring is condensed on the nitrogen atom of amido group and possession of a lower alkylamino or an amino group substituted with a ring group at the neighboring position of said amido group has a strong inhibitory action on VR1 activation and excellent pharmacological actions based on this and by finding that it can become an excellent agent for treating or preventing VR1-involved diseases such as nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like.
    本发明提供了一种基于对辣椒素受体VR1激活的抑制作用的新型优良药剂,用于治疗或预防伤害性疼痛、神经病理性疼痛、癌症疼痛、头痛、膀胱功能障碍等疾病。本发明通过确认一种苯甲酰胺衍生物,其特征在于其苯环上的单环在酰胺基氮原子上被紧缩,其低烷基基或邻位于酰胺基的环基取代的基具有对VR1激活的强抑制作用和优良的药理作用,从而发现它可以成为治疗或预防伤害性疼痛、神经病理性疼痛、癌症疼痛、头痛、膀胱功能障碍等VR1相关疾病的优良药剂。
  • ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE
    申请人:MITA Takeshi
    公开号:US20110251398A1
    公开(公告)日:2011-10-13
    A 3,5-Bis (substituted aryl) substituted isoxazoline compound of formula (2) or a salt thereof: wherein A1 is a carbon atom or nitrogen atom; X1 is selected from the group consisting of a halogen atom, —SF5, C1-C6haloalkyl, hydroxy C1-C6haloalkyl, C1-C6alkoxy C1-C6haloalkyl, C1-C6haloalkoxy C1-C6haloalkyl, C3-C8halocycloalkyl, C1-C6haloalkoxy, C1-C3haloalkoxy C1-C3haloalkoxy, C1-C6haloalkylthio, C1-C6haloalkylsulfinyl and C1-C6haloalkylsulfonyl; X2 is selected from the group consisting of a halogen atom, cyano, nitro, C1-C6alkyl, C1-C6haloalkyl, —OR5, —OSO2R5 and —S(O)rR5; Y is selected from the group consisting of a halogen atom, cyano, nitro, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C6alkylthio, C1-C6haloalkylthio, C1-C6alkylsulfonyl, C1-C6haloalkylsulfonyl, —NHR7 and —N(R7)R6; R is selected from the group consisting of a halogen atom, cyano, nitro, —NH2, halosulfonyloxy, C1-C6alkylsulfonyloxy, C1-C6haloalkylsulfonyloxy, phenylsulfonyloxy, phenylsulfonyloxy substituted with (Z)p1 and —C(O)Ra; m1 is an integer of 0 to 2; n is an integer of 0 or 1; p1 is an integer of 1 to 5; and r is an integer of 0 to 2.
    化合物公式为(2)的3,5-双(取代芳基)取代异噁唑化合物或其盐: 其中,A1为碳原子或氮原子;X1选自卤素原子、—SF5、C1-C6卤代烷基、羟基C1-C6卤代烷基、C1-C6烷氧基C1-C6卤代烷基、C1-C6卤代烷氧基C1-C6卤代烷基、C3-C8卤代环烷基、C1-C6卤代烷氧基、C1-C3卤代烷氧基C1-C3卤代烷氧基、C1-C6卤代烷基、C1-C6卤代烷基亚砜和C1-C6卤代烷基磺酰基;X2选自卤素原子、基、硝基、C1-C6烷基、C1-C6卤代烷基、—OR5、—OSO2R5和—S(O)rR5;Y选自卤素原子、基、硝基、C1-C4烷基、C1-C4卤代烷基、C1-C4烷氧基、C1-C4卤代烷氧基、C1-C6烷基、C1-C6卤代烷基、C1-C6烷基磺酰基、C1-C6卤代烷基磺酰基、—NHR7和—N(R7)R6;R选自卤素原子、基、硝基、—NH2、卤代磺酸酯氧基、C1-C6烷基磺酸酯氧基、C1-C6卤代烷基磺酸酯氧基、苯基磺酸酯氧基、苯基磺酸酯氧基,其取代基为(Z)p1和—C(O)Ra;m1为0至2的整数;n为0或1的整数;p1为1至5的整数;r为0至2的整数。
  • 2-AMINOBENZAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) INHIBITORS USEFUL FOR THE TREATMENT OF PAIN OR BLADDER FUNCTION DISORDER
    申请人:Astellas Pharma Inc.
    公开号:EP1955697B1
    公开(公告)日:2012-05-02
查看更多